QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced
today that it plans to provide in the first half of July 2020 an
overview of preliminary results for the second quarter and first half of
2020, along with perspectives on anticipated business trends for the
third quarter of 2020. The release of full second quarter 2020 results
remains planned for August 4, 2020.
In addition, QIAGEN intends to update previously communicated
expectations for growth trends for the full year and share incremental
perspectives on the potential impact of the coronavirus pandemic on
QIAGEN’s business.
The release of preliminary results in the first half of July will
occur during the current voluntary tender offer made by Thermo Fisher
Scientific Inc. (NYSE: TMO) for all of the issued shares of QIAGEN at an
offer price of EUR 39 per share in cash. The period for acceptance of
the recommended tender offer commenced on May 18, 2020, and is currently
scheduled to end on July 27, 2020, 24:00 hours CEST (18:00 hours New
York local time).
The Managing Board and Supervisory Board continue to unanimously
recommend that QIAGEN shareholders accept the tender offer by tendering
their shares, and also to vote in favor of related transaction
resolutions on the agenda at QIAGEN’s Annual General Meeting scheduled
for June 30, 2020.
The Offer Document is published on Thermo Fisher’s website, in the German language at https://corporate.thermofisher.com/en/offer.html?lang=de and in the English language at https://corporate.thermofisher.com/en/offer.html/.
In response to the Offer Document, QIAGEN published on May 18, 2020,
the Joint Reasoned Position Statement, which remains available on
QIAGEN’s website at
in the German language, and at
in the English language.
https://www.marketscreener.com/QIAGEN-N-V-40135659/news/Qiagen-N-Announces-Plans-to-Release-Preliminary-Q2-2020-Results-30807299/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.